A new cell therapy (SBT777101) for rheumatoid arthritis

You may qualify if

• Body mass index (BMI) <35 kg/m^2, inclusive
• Adult-onset, moderate-to-severe rheumatoid arthritis (RA)
• Moderate-to-severe active disease
• Clinical and/or ultrasound evidence of synovitis
• Prior inadequate response to or unable to tolerate available RA therapies
• Stable doses of RA medications for at least 30 days
• Use of highly effective methods of contraception

You can't join if

• Major surgery within 12 weeks prior to screening or planned within 12 months after dosing
• Uncontrolled cardiovascular, pulmonary, renal, hepatic, endocrine, or gastrointestinal disease
• Recurrent infections or active infection
• Active or untreated latent tuberculosis
• Primary or secondary immunodeficiency
• History of or current inflammatory joint disease other than RA